MEDIC Life Sciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $7M

  • Investors
  • 16

MEDIC Life Sciences General Information

Description

Operator of a functional genomics and precision oncology platform engineered to discover novel therapeutic targets and synthetic lethal biomarkers for solid tumor treatments. The company utilizes massive high-throughput three-dimensional cancer spheroid models, whole-genome CRISPR screening, and a tumor-immune co-culture system across its core technologies, enabling biopharmaceutical developers, clinical trial operators, and oncology research teams to measure millions of gene-to-drug interactions and rescue clinical-stage therapeutic assets by refining patient selection criteria.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 950 Page Mill Road
  • Palo Alto, CA 94304
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 950 Page Mill Road
  • Palo Alto, CA 94304
  • United States

MEDIC Life Sciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MEDIC Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A1) 19-Jun-2026 $7M Completed Generating Revenue
4. Later Stage VC (Series A) 15-Oct-2024 Cancelled Generating Revenue
3. Later Stage VC (Series A) 14-Oct-2024 Completed Product Development
2. Seed Round 27-Jul-2023 $8M $8M Completed Product Development
1. Accelerator/Incubator 23-Jun-2020 Completed Product Development
To view MEDIC Life Sciences’s complete valuation and funding history, request access »

MEDIC Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-3
Series A-2
Seed-6
Seed-5
Seed-4
Seed-3
Seed-2 1,873,535 $0.000010 $1.07 $1.07 1x $1.07 5.26%
Seed-1 2,752,434 $0.000010 $1.33 $1.33 1x $1.29 8%
To view MEDIC Life Sciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MEDIC Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a functional genomics and precision oncology platform engineered to discover novel therapeutic targets and s
Drug Discovery
Palo Alto, CA
17 As of 2026

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MEDIC Life Sciences Competitors (1)

One of MEDIC Life Sciences’s competitors is KSQ, a Venture Capital-Backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
KSQ Venture Capital-Backed Lexington, MA
You’re viewing 1 of 1 competitors. Get the full list »

MEDIC Life Sciences Patents

MEDIC Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3226294-A1 High-throughput screening system for identification of novel drugs and drug targets Pending 08-Jul-2021
EP-4366836-A2 High-throughput screening system for identification of novel drugs and drug targets Pending 08-Jul-2021
US-11802866-B2 High-throughput screening system for identification of novel drugs and drug targets Active 08-Jul-2021
US-12038431-B2 High-throughput screening system for identification of novel drugs and drug targets Active 08-Jul-2021
US-20230027352-A1 High-throughput screening system for identification of novel drugs and drug targets Active 08-Jul-2021 G01N33/5008
To view MEDIC Life Sciences’s complete patent history, request access »

MEDIC Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MEDIC Life Sciences Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Groom Investment PE/Buyout Minority
LINE Investment Partners Venture Capital Minority
Loftyrock Investment Venture Capital Minority
Hanmi Pharmaceutical Corporation Minority
LG Holding Company Minority
You’re viewing 5 of 16 investors. Get the full list »

MEDIC Life Sciences FAQs

  • When was MEDIC Life Sciences founded?

    MEDIC Life Sciences was founded in 2019.

  • Where is MEDIC Life Sciences headquartered?

    MEDIC Life Sciences is headquartered in Palo Alto, CA.

  • What is the size of MEDIC Life Sciences?

    MEDIC Life Sciences has 17 total employees.

  • What industry is MEDIC Life Sciences in?

    MEDIC Life Sciences’s primary industry is Drug Discovery.

  • Is MEDIC Life Sciences a private or public company?

    MEDIC Life Sciences is a Private company.

  • What is the current valuation of MEDIC Life Sciences?

    The current valuation of MEDIC Life Sciences is .

  • What is MEDIC Life Sciences’s current revenue?

    The current revenue for MEDIC Life Sciences is .

  • How much funding has MEDIC Life Sciences raised over time?

    MEDIC Life Sciences has raised $20M.

  • Who are MEDIC Life Sciences’s investors?

    Groom Investment, LINE Investment Partners, Loftyrock Investment, Hanmi Pharmaceutical, and LG are 5 of 16 investors who have invested in MEDIC Life Sciences.

  • Who are MEDIC Life Sciences’s competitors?

    KSQ is a competitor of MEDIC Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process